Global Multi Cancer Screening Market Growth (Status and Outlook) 2025-2031

The global Multi Cancer Screening market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Multi Cancer Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Multi Cancer Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Multi Cancer Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Multi Cancer Screening players cover Guardant Health, GRAIL, Burning Rock, Thermo Fisher Scientific, Exact Sciences Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Multi Cancer Screening Industry Forecast” looks at past sales and reviews total world Multi Cancer Screening sales in 2024, providing a comprehensive analysis by region and market sector of projected Multi Cancer Screening sales for 2025 through 2031. With Multi Cancer Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Multi Cancer Screening industry.

This Insight Report provides a comprehensive analysis of the global Multi Cancer Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Multi Cancer Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Multi Cancer Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Multi Cancer Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Multi Cancer Screening.

This report presents a comprehensive overview, market shares, and growth opportunities of Multi Cancer Screening market by product type, application, key players and key regions and countries.

Segmentation by Type:

Laboratory Developed Tests (LDTs)

In-Vitro Diagnostics (IVDs)

Segmentation by Application:

Hospitals

Clinic

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Guardant Health

GRAIL

Burning Rock

Thermo Fisher Scientific

Exact Sciences Corporation

Fulgent Genetics

Genecast Biotechnology

Agilent Technologies

Atara Biotherapeutics

Konica Minolta

Tempus

Myriad Genetics

Laboratory Corporation

Please note: The report will take approximately 2 business days to prepare and deliver.